Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sequential Expansion of Comparative Effectiveness of Oral Anticoagulants: A Cohort Study

Next Previous
Trial Profile

Sequential Expansion of Comparative Effectiveness of Oral Anticoagulants: A Cohort Study

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Warfarin
  • Indications Embolism and thrombosis; Haemorrhage; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RE-LY
  • Sponsors Boehringer Ingelheim

Most Recent Events

  • 18 May 2022 Results an analysis assessing cost-effectiveness of dabigatran compared to acenocoumarol, rivaroxaban and apixaban for thromboembolic events prevention in atrial fibrillation patients using clinical data from this trial and from a NMA published by Lopez-Lopez et al presented at the 27th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
  • 25 Aug 2021 Results assessing Plasmode Simulation of Covariate Misclassification and Transportability from individual-level data from the Randomized Evaluation of Long-Term Anticoagulation (RE-and target population of warfarin initiators in a 20% random sample of Medicare participants LY) trial presented at the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
  • 20 Mar 2021 Results (n=18113) assessing patients at risk for cardiovascular events according to their pharmacological treatment intensity and adherence, published in the American Journal of Cardiology.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top